Anna Mapp

Title: Anna Mapp: Innovator in p53 Reactivation

Introduction

Anna Mapp is a distinguished inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of biochemistry, particularly in the area of p53 reactivation. With a total of 3 patents, her work has the potential to impact cancer research and treatment.

Latest Patents

Among her latest patents is the invention titled "Oligooxopiperazines for p53 reactivation." This invention relates to oligooxopiperazines that comprise two or three oxopiperazine rings, which substantially mimic helix αB of the C-terminal transactivation domain of Hypoxia-Inducible Factor 1α. The methods of using these oligooxopiperazines are also disclosed, providing a promising avenue for therapeutic applications. Another notable patent is "Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation." This invention focuses on peptidomimetics designed for reactivating p53, along with methods for their application.

Career Highlights

Anna Mapp has held positions at prestigious institutions, including the University of Michigan and New York University. Her academic and research endeavors have positioned her as a leading figure in her field, contributing to advancements in cancer research.

Collaborations

Throughout her career, Anna has collaborated with notable colleagues such as Paramjit S Arora and Quintin Pan. These partnerships have further enriched her research and innovation efforts.

Conclusion

Anna Mapp's work in p53 reactivation exemplifies the intersection of innovation and scientific research. Her contributions continue to pave the way for advancements in cancer treatment and understanding.